A Phase II Study of Docetaxel and Infusional Cisplatin in Advanced Non-Small-Cell Lung Cancer

Publisher： Karger

E-ISSN： 1421-9794|51|2-3|120-125

ISSN： 0009-3157

Source： Chemotherapy, Vol.51, Iss.2-3, 2005-06, pp. : 120-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Trial of Biweekly Chemotherapy with Docetaxel and Cisplatin in High-Risk Patients with Unresectable Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 59, Iss. 3, 2013-10 ,pp. : 159-166

Karger

Access to resources Recommend Favorite

Phase II Study of Pemetrexed and Erlotinib in Pretreated Nonsquamous, Non-Small-Cell Lung Cancer Patients without an EGFR mutation

By  

Chemotherapy, Vol. 59, Iss. 6, 2014-07 ,pp. : 414-419

Karger

Access to resources Recommend Favorite

Low-Dose Weekly Docetaxel Is as Tolerable as Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer

By  

Chemotherapy, Vol. 57, Iss. 2, 2011-03 ,pp. : 147-155

Karger

Access to resources Recommend Favorite

A Phase II Study of S-1 for Previously Untreated Elderly Patients with Advanced Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 61, Iss. 2, 2015-0 ,pp. : 93-98

Karger

Access to resources Recommend Favorite

A Phase II Study of First-Line Chemotherapy with Weekly Carboplatin Plus Gemcitabine in Advanced Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 58, Iss. 1, 2012-02 ,pp. : 78-83

Karger

Access to resources Recommend Favorite